Frequency and Predictors of Shape/Weight Concerns and Objective Binge Eating in Avoidant/Restrictive Food Intake Disorder (ARFID).
Saved in:
| Title: | Frequency and Predictors of Shape/Weight Concerns and Objective Binge Eating in Avoidant/Restrictive Food Intake Disorder (ARFID). |
|---|---|
| Authors: | Kambanis, P. Evelyna, Palmer, Lilian P., Jhe, Grace, McPherson, Iman, Graver, Haley, Dalton, Abigail G., Ji, Chunni, Asanza, Elisa, Shabazian, Lauren, Dunford, Ashley, Breithaupt, Lauren, Freizinger, Melissa, Eddy, Kamryn T., Misra, Madhusmita, Micali, Nadia, Holsen, Laura, Lawson, Elizabeth A., Becker, Kendra R., Thomas, Jennifer J. |
| Source: | International Journal of Eating Disorders. May2025, Vol. 58 Issue 5, p986-992. 7p. |
| Subjects: | Diagnosis of eating disorders, Bulimia, Secondary analysis, Body mass index, T-test (Statistics), Research funding, Body weight, Interviewing, Questionnaires, Body image, Classification of mental disorders, Descriptive statistics, Analysis of covariance, Eating disorders, Research methodology, Data analysis software, Regression analysis, Psychosocial factors |
| Abstract: | Objective: DSM‐5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co‐occur, and DSM‐5‐TR now permits comorbid binge‐eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical‐level shape/weight concerns and past‐month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical‐level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory. Method: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination—Questionnaire (EDE‐Q). Results: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical‐level shape/weight concerns, and 15% reported past‐month OBEs. Higher weight uniquely predicted shape/weight concerns. Discussion: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID—particularly those at higher weights—may experience clinical‐level shape/weight concerns and OBEs. [ABSTRACT FROM AUTHOR] |
| Copyright of International Journal of Eating Disorders is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objective: DSM‐5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co‐occur, and DSM‐5‐TR now permits comorbid binge‐eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical‐level shape/weight concerns and past‐month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical‐level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory. Method: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination—Questionnaire (EDE‐Q). Results: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical‐level shape/weight concerns, and 15% reported past‐month OBEs. Higher weight uniquely predicted shape/weight concerns. Discussion: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID—particularly those at higher weights—may experience clinical‐level shape/weight concerns and OBEs. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 02763478 |
| DOI: | 10.1002/eat.24398 |
